Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are adults (18 years of age or older).
- People who are covered by a social security scheme (such as health insurance through a social security system).
- People who have been diagnosed with Chronic Myeloid Leukemia (a type of blood cancer) and are currently taking one of the following medicines: Imatinib, Nilotinib, Dasatinib, or Bosutinib.
- People whose blood cancer is still detectable at a certain level — specifically, where the amount of cancer-related genetic material in the blood has not dropped below a level called "4.5 Log" (confirm with trial site for what this means in your specific situation).
Who may not be able to join:
- People who do not have the legal or mental capacity to make their own decisions about participating.
- People who are unable to read and/or write in French.
- People who are currently taking the medicine Ponatinib.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xavier SIMOENS, MD, PhD, CHU de Saint-Etienne
Phone: 0477822875
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients for whom pharmaceutical interventions have been done
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.